Helicobacter pylori infection and comorbidity: Our diagnostic and therapeutic modalities

Sabir Sagdati ,
Sabir Sagdati
Srbislava Milinic ,
Srbislava Milinic
Predrag Dugalic
Predrag Dugalic

Published: 01.12.2012.

Biochemistry

Volume 29, Issue 1 (2013)

pp. 813-818;

https://doi.org/10.5937/matmed1301813s

Abstract

The discovery of Helicobacter pylori (Hp) bacteria and causal relationship of Helicobacter pylori infection with the origin of chronic gastritis, stomach and duodenal ulcer and stomach cancer represents an epochal event of the new age. The goal of the study is to examine the incidence of Helicobacter pylori infection of stomach and prove the connection between Helicobacter pylori infection and stomach and duodenum diseases (non-ulcer gastropathy, stomach ulcer, and duodenal bulb ulcer and stomach cancer). The study encompassed 250 randomly selected examinees of both genders and different age categories. All the examinees were subjected to quick urease test (QUT) from antral bioptate and stomach corpus acquired by upper gastrointestinal endoscopy with standard forceps. Hp positive examinees were subjected to one of four therapy protocols for eradication of Hp. The acquired data were treated with application of descriptive statistical methods (SV, SD, Min, MAX) and analytical statistical methods (Student t test, Hi quadrat test, Kruskal-Walish test, Mann-Whitny U-test, Wilcoxon test, ANOVA variant analysis, Spearman and Pearson correlation). 250 examinees tested by quick urease test (QUT), 54% were positive and 46% were negative (p>0.05). The proportion by genders between QUT positives and QUT negatives was approximately the same (p>0.05). Non-ulcer gastropathy was a dominant finding with both QUT negatives (92.2%) and QUT positives (77%) (p<0.01). The highest rate of eradication of Helicobacter pylori infection was shown by protocols B and D (75%), then protocol A (71%) and protocol C (57.2%) (p>0.05). Quick urease test (QUT) which requires upper digestive endoscopy and biopsy of stomach epithelia samples represents a minimum of invasive diagnostics of Helicobacter pylori infection and a minimum of confirmation of eradication in our conditions. Therapeutic protocols B and D have shown the highest rate of success in eradication with our patients.

Keywords

References

1.
Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Microbios Lett. 1983;83–8.
2.
Harris Aw M, Gjj, Helicobacter Pylori, London. 1997;
3.
Helicobacter pylori infection and dyspepsia. Gastroenterol. 1996;38–47.
4.
Kliničke G. endoskopske i histološke karakteristike oboljenja gastroduodenuma u pacijenata sa Helicobacter pylori infekcijom. doktorska disertacija. 2001;
5.
1997;90–101.
6.
Bulajić M, Milosavljević T, Vranješ N. Helicobacter pylori infekcija.arch gastroenterohepatol. 1996;22–3.
7.
I. Klinička studija povezanosti Helicobacter pylori infekcije i sindroma gornje dispepsije. Magistarski rad. Univerzitet u Beogradu, Medicinski fakultet. 1998;
8.
Mijalković N. Klinički značaj povezanosti Helicobacter pylori infekcije i ulkusne bolesti želuca. Magistarski rad. 1999;
9.
Talley Nj, Zinsmeister Ar, Weaver. gastric adenocarcinoma and Helicobacter pylori. Ntl Cancer inst. 1991;1734–9.
10.
Milosavljević T. Helicobacter pylori i oboljenja digestivnog sistema: Petnaest godina kasnije. Gastroenterohepatol. 1998;
11.
Milosavljević T. Helicobacter pylori u kliničkoj praksi.Beograd:Vreme knjige. 1996;
12.
Milosavljević T, Helicobacter I. Elektronsko Cd rom izdanj dandesign i Medicinski fakultet. 1999;
13.
Milosavljević T, Petrović V. Helicobacter pylori 100 pitanja i odgovora. Hemofarm Vršac. 2000;
14.
Bazzoli F. Key points from the revised Maastricht consensus report:the impact on general practice. Eur j Gastroenterol Hepatol. 2001;(2):3–7.
15.
Casseli M, Trevisanil T. short-term low-dose triple terapy with azithromicin,metronidazole and lansoprazole appers higly effective for the eradication of Helicobacter pylori. Eur j Gastroenterol Hepatol. 1997;45–8.
16.
Grgov s, stefanović M. dual, triple and quadruple therapy for Helicobacter pylori eradication. Gastroenterohepatol. 1998;9–14.
17.
Labenz J, Tillenburg B, Peitz U, Borrsch G. Long-term consequences of Helicobacter pylori eradication: Clinical aspects. scand j Gastroenterol. 1996;111–5.
18.
Tasić G, T. Nekoliko modaliteta trostruke terapije Helicobacter pylori infekcije. 2004;
19.
Bj M, Jr W. autor za korespondenciju: sabir sagdati, General Hospital, Novi Pazar General Zivkovic 1, 36300 Novi Pazar. Lancet. 1984;1311–5.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners